Literature DB >> 3948627

Gastrointestinal symptoms of patients with esophageal contraction abnormalities.

R E Clouse, T C Eckert.   

Abstract

Nonesophageal, gastrointestinal symptoms were sought from consecutive patients referred for esophageal manometry in order to determine the prevalence of such symptoms in relation to manometric diagnosis. Reports by 103 patients with esophageal contraction abnormalities, a cluster of manometric findings which includes the "nutcracker esophagus" and diffuse esophageal spasm, were compared to those by patients with the achalasia pattern (21 patients) and scleroderma esophagus (19 patients). A history of persistent (greater than 3 months) bowel habit abnormality requiring medical attention was reported by 19% of those with contraction abnormalities and 26% of those with scleroderma esophagus but by no patient with achalasia (P less than 0.05 for both compared to achalasia). Patients with contraction abnormalities had complained to physicians of more gastrointestinal symptoms and had more often been diagnosed as having the irritable bowel syndrome than those with achalasia. We conclude that, with regard to gastrointestinal symptoms, patients with esophageal contraction abnormalities more closely resemble patients with a motility disorder which has the potential for diffuse symptomatic gastrointestinal involvement (scleroderma) than those with a motility disorder restricted to the esophagus (achalasia). These findings add support to the argument that functional gastrointestinal syndromes may be representative of diffuse neuromuscular derangement in the gastrointestinal tract.

Entities:  

Mesh:

Year:  1986        PMID: 3948627     DOI: 10.1007/bf01318113

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  The natural history of achalasia of the cardia.

Authors:  F G ELLIS
Journal:  Proc R Soc Med       Date:  1960-08

2.  Improved infusion system for intraluminal esophageal manometry.

Authors:  R C Arndorfer; J J Stef; W J Dodds; J H Linehan; W J Hogan
Journal:  Gastroenterology       Date:  1977-07       Impact factor: 22.682

3.  Esophageal spasm and psychiatric disorder.

Authors:  M M Schuster
Journal:  N Engl J Med       Date:  1983-12-01       Impact factor: 91.245

Review 4.  The irritable bowel.

Authors:  W G Thompson
Journal:  Gut       Date:  1984-03       Impact factor: 23.059

5.  Scleroderma esophagus: a nonspecific entity.

Authors:  H A Schneider; R A Yonker; S Longley; P Katz; J Mathias; R S Panush
Journal:  Ann Intern Med       Date:  1984-06       Impact factor: 25.391

6.  Manometric findings during spontaneous chest pain in patients with presumed esophageal "spasms".

Authors:  R E Clouse; A Staiano; D W Landau; J L Schlachter
Journal:  Gastroenterology       Date:  1983-08       Impact factor: 22.682

7.  Heartburn and globus in apparently healthy people.

Authors:  W G Thompson; K W Heaton
Journal:  Can Med Assoc J       Date:  1982-01-01       Impact factor: 8.262

8.  Psychiatric illness and contraction abnormalities of the esophagus.

Authors:  R E Clouse; P J Lustman
Journal:  N Engl J Med       Date:  1983-12-01       Impact factor: 91.245

9.  Prospective manometric evaluation with pharmacologic provocation of patients with suspected esophageal motility dysfunction.

Authors:  S B Benjamin; J E Richter; C M Cordova; T E Knuff; D O Castell
Journal:  Gastroenterology       Date:  1983-05       Impact factor: 22.682

10.  Globus and headache: common symptoms of the irritable bowel syndrome.

Authors:  W C Watson; S N Sullivan; M Corke; D Rush
Journal:  Can Med Assoc J       Date:  1978-02-18       Impact factor: 8.262

View more
  10 in total

1.  Gallbladder function and gastric liquid emptying in achalasia.

Authors:  V Annese; N Caruso; L Accadia; A Gabbrielli; S Modoni; V Frusciante; T Federici
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

Review 2.  Inflammation in irritable bowel syndrome: Myth or new treatment target?

Authors:  Emanuele Sinagra; Giancarlo Pompei; Giovanni Tomasello; Francesco Cappello; Gaetano Cristian Morreale; Georgios Amvrosiadis; Francesca Rossi; Attilio Ignazio Lo Monte; Aroldo Gabriele Rizzo; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

3.  Modulation of human upper gastrointestinal motility by rectal distension.

Authors:  J E Kellow; R C Gill; D L Wingate
Journal:  Gut       Date:  1987-07       Impact factor: 23.059

4.  An approach to diarrhea with emphasis on the irritable bowel syndrome.

Authors:  T Lay
Journal:  Can Fam Physician       Date:  1988-03       Impact factor: 3.275

Review 5.  Functional findings in irritable bowel syndrome.

Authors:  Iris Posserud; Amanda Ersryd; Magnus Simrén
Journal:  World J Gastroenterol       Date:  2006-05-14       Impact factor: 5.742

6.  Influence of spastic motor disorders of the esophageal body on outcomes from laparoscopic antireflux surgery.

Authors:  E R Winslow; R E Clouse; K M Desai; P Frisella; T Gunsberger; N J Soper; M E Klingensmith
Journal:  Surg Endosc       Date:  2003-03-07       Impact factor: 4.584

Review 7.  Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 2. Motility of the small bowel, esophagus, stomach, and gall-bladder.

Authors:  D P McKee; E M Quigley
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

Review 8.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

9.  Visceral perception in health and functional dyspepsia. Crossover study of gastric distension with placebo and domperidone.

Authors:  M Bradette; P Pare; P Douville; A Morin
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

Review 10.  Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (review).

Authors:  Magdy El-Salhy; Odd Helge Gilja; Doris Gundersen; Jan G Hatlebakk; Trygve Hausken
Journal:  Int J Mol Med       Date:  2014-06-17       Impact factor: 4.101

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.